Table 5. The effects of the onset time of jaundice and TSB level on the severity of ABE and prognosis.
Without ABE(n = 246) | Mild ABE(n = 213) | ModerateABE(n = 88) | Severe ABE(n = 67) | P1 | Poor prognosis(n = 43) | P2 | OR | 95%CI | ||
---|---|---|---|---|---|---|---|---|---|---|
Age on admission (h) | ≤24 | 112(45.5%) | 101(47.4%) | 47(53.4%) | 28(41.8%) | 0.881 | 14 | 0.252 | ||
24~48 | 96(39.0%) | 77(36.2%) | 25(28.4%) | 26(38.8%) | 21 | |||||
48~72 | 28(11.4%) | 27(12.7%) | 13(14.8%) | 10(14.9%) | 6 | |||||
>72 | 10(4.1%) | 8(3.8%) | 3(3.4%) | 3(4.5%) | 2 | |||||
TSBpre-ECT(μmol/L) | ≤255 | 14(5.7%) | 8(3.8%) | 3(3.4%) | 1(1.5%) | <0.001 | 0 | 0.008 | ||
255~340 | 31(12.6%) | 22(10.3%) | 5 (5.7%) | 4(6.0%) | 5 | |||||
340~425 | 76(30.9%) | 56(26.3%) | 21(23.9%) | 8(11.9%) | 6 | |||||
425~510 | 80(32.5%) | 72(33.8%) | 31(35.2%) | 17(25.4%) | 11 | |||||
>510 | 45(18.3%) | 55(25.8%) | 28(31.8%) | 37(55.2%) | 21 | |||||
TSBpre-ECT> 340 μmol/L | No | 45(18.3%) | 30(14.1%) | 8 (9.1%) | 5(7.5%) | 0.053 | 5 | 0.6 | 1.293 | 0.494~3.379 |
Yes | 201(81.7%) | 183(85.9%) | 80(90.9%) | 62(92.5%) | 38 | |||||
TSBpre-ECT> 425 μmol/L | No | 121(49.2%) | 86(40.4%) | 29(33.0%) | 13(19.4%) | <0.001 | 11 | 0.038 | 2.079 | 1.027~4.028 |
Yes | 125(50.8%) | 127(59.6%) | 59(67.0%) | 54(80.6%) | 32 | |||||
TSBpre-ECT> 510 μmol/L | No | 201(81.7%) | 158(74.2%) | 60(68.2%) | 30(44.8%) | <0.001 | 22 | 0.001 | 2.83 | 1.512~5.299 |
Yes | 45(18.3%) | 55(25.8%) | 28(31.8%) | 37(55.2%) | 21 |